As of 2025-09-28, the Relative Valuation of Dawnrays Pharmaceutical (Holdings) Ltd (2348.HK) is 2.87 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 1.21 HKD, the upside of Dawnrays Pharmaceutical (Holdings) Ltd based on Relative Valuation is 137.4%.
The range of the Relative Valuation is 1.34 - 4.87 HKD.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 13.3x | 11.9x |
| Forward P/E multiples | 9.3x - 12.0x | 10.4x |
| Fair Price | 1.34 - 4.87 | 2.87 |
| Upside | 10.9% - 302.2% | 137.4% |
| Date | P/E |
| 2025-09-26 | 9.43 |
| 2025-09-25 | 9.51 |
| 2025-09-24 | 9.59 |
| 2025-09-23 | 9.59 |
| 2025-09-22 | 9.43 |
| 2025-09-19 | 9.43 |
| 2025-09-18 | 9.43 |
| 2025-09-17 | 9.51 |
| 2025-09-16 | 9.59 |
| 2025-09-15 | 9.43 |
| 2025-09-12 | 9.51 |
| 2025-09-11 | 9.59 |
| 2025-09-10 | 9.59 |
| 2025-09-09 | 9.67 |
| 2025-09-08 | 9.67 |
| 2025-09-05 | 9.75 |
| 2025-09-04 | 9.59 |
| 2025-09-03 | 9.82 |
| 2025-09-02 | 9.67 |
| 2025-09-01 | 9.67 |
| 2025-08-29 | 9.82 |
| 2025-08-28 | 9.51 |
| 2025-08-27 | 9.51 |
| 2025-08-26 | 9.75 |
| 2025-08-25 | 9.75 |
| 2025-08-22 | 10.06 |
| 2025-08-21 | 10.14 |
| 2025-08-20 | 10.06 |
| 2025-08-19 | 10.21 |
| 2025-08-18 | 10.21 |
| 2025-08-15 | 10.53 |
| 2025-08-14 | 10.45 |
| 2025-08-13 | 10.76 |
| 2025-08-12 | 10.84 |
| 2025-08-11 | 10.68 |
| 2025-08-08 | 10.60 |
| 2025-08-07 | 10.60 |
| 2025-08-06 | 10.60 |
| 2025-08-05 | 10.68 |
| 2025-08-04 | 10.60 |
| 2025-08-01 | 10.45 |
| 2025-07-31 | 10.76 |
| 2025-07-30 | 10.84 |
| 2025-07-29 | 11.07 |
| 2025-07-28 | 11.07 |
| 2025-07-25 | 10.60 |
| 2025-07-24 | 10.60 |
| 2025-07-23 | 10.45 |
| 2025-07-22 | 10.37 |
| 2025-07-21 | 10.68 |